Modifiable risk factors stand out today as significant contributors to diseases, and yet we as an industry haven't tackled this. Instead, we sit by almost passively as obesity, diabetes and hypertension rates continue to skyrocket. In fact, obesity and overweight is now over 70% of the US population and has turned into the forgotten pandemic. Globally, no country in the world has improved their obesity percentage rates during the past 15 years. Insurers are starting to explore health interventions which have the potential to reduce claims and change people's behaviour. Our presentation with a focus on metabolic health through the eyes of health interventions will explore:•The case for intervention programs, such as weakening of long-term mortality impacts due to obesity, and diabetes on the rise •An understanding of the different intervention programs in the global market today, such as various InsurTechs, and where the focus is, e.g., cancer, metabolic health, genetics, smoking, etc..•How to create the business case and get the best bang for your buck•Looking at case studies of how insurers are looking to reduce claims and offer interventions•How metabolic health is a key focus area and the potential mortality improvements•Understanding the challenge of focusing on the right group of people to get maximum impact at lowest cost and how this drives actuarial impacts•How in the future this could be further introduced into the underwriting journey TRACK: Health : Design and Pricing;Pricing/ Product Development (Underwriting, ULSG, Etc.)
Edition